secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K/A
Filed at:   2022-07-18T23:59:59+00:00
Accession:  0001077183-22-000120
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics subsidiary settles with former CEO Clive Morris for £607,500 in termination payments
--------------------------------------------------------------------------------

- Settlement includes £202,500 payment in lieu of notice, £303,750 retention cash bonus component, and £101,250 pro-rated MIP bonus.
- Additional payment for accrued vacation and legal fees up to £2,000 plus VAT.
- Dr. Morris served as CEO of Inivata Limited, a wholly owned NeoGenomics subsidiary; employment terminated June 30, 2022.
- Agreement includes full release of claims, confidentiality, and non-disparagement obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000120/0001077183-22-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000120/neo-20220505.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer